Recruiting NA Aphakia

New treatment option for Aphakia

Official title Clareon TruPlus Study

ClinicalTrials.gov ID: NCT07502456

What this study is testing

What it's testing
The purpose of this research study is to generate safety and performance data for Clareon TruPlus Monofocal Intraocular Lenses (IOLs). IOLs are medical devices that are implanted in the eye during cataract surgery to restore clear vision after the cloudy natural lens has been removed.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 22 and older

You may be able to join if

  • Diagnosed with bilateral cataracts and planned bilateral cataract extraction by routine phacoemulsification.
  • Potential postoperative BCDVA of 0.2 logMAR or better in each eye in the expert medical opinion of the investigator.
  • Astigmatism suitable for correction with available toric IOL models.
  • Other protocol-specified may apply. Key

You likely can't join if

  • Age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and other eye conditions as specified in the protocol.
  • Moderate to severe dry eye that would affect study measurements.
  • Other protocol-specified exclusion criteria may apply.

The study team makes the final eligibility decision.

Where it's taking place

  • Phoenix, Arizona, United States
  • Brecksville, Ohio, United States
  • Mt. Pleasant, South Carolina, United States
  • Sugar Land, Texas, United States
  • Salt Lake City, Utah, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 22 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Phoenix, Arizona, United States; Brecksville, Ohio, United States; Mt. Pleasant, South Carolina, United States; Sugar Land, Texas, United States; Salt Lake City, Utah, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.